ALFA Finder| Revenue growth | Q2 revenue ₹135.6 Cr, +14.1% YoY, volume-driven. |
|---|---|
| Margins | EBITDA margin 21.5% Q2, +150bps YoY; H1 21%, +221bps. |
| Demand visibility | International patient flow slowly recovering; Bangladesh visa requests rising. |
| Management confidence | Balanced-to-optimistic; FY27 growth reiterated, Raipur timelines slipped. |
Growth
Revenue +14.1%, EBITDA +23.9%, PAT +45.2% YoY; growth volume-led (~11% patient volume) with ARPOB +7.1%, occupancy 50.3% vs 47.4%.
Outlook
FY27 growth guided at 15-16% (metric unspecified); Raipur FY27 loss ~₹10 Cr; Jamshedpur 155 beds, Mar-Apr 2027.
Risks
Raipur ~₹9 Cr Q2 loss and slipped break-even; Artemis entry caused talent attrition; Supreme Court trade-margin ruling pending.
Last quarter's promises, checked
Delivered
- EBITDA 'improve vs last year' → EBITDA +23.9% YoY (= BEAT)
Partly delivered
- FY27 EBITDA margin ~21% (+200bps) → H1 21.0%, +221bps (= PARTIAL, FY not closed)
- Jamshedpur 155 beds 'late Q4 FY27' → now Mar–Apr 2027 (= PARTIAL)
Missed
- Raipur Q1 loss ₹3 Cr, 'taper through year' → Q2 loss ~₹9 Cr (= MISS)
- Raipur breakeven ~20-month mark → slipped to Q1 FY28 (= MISS)
Earnings Call Transcript filed with NSE, NSE: GPTHEALTH. Summary written with AI assistance from the document.
GPT Healthcare Ltd: key numbers
- Share price
- ₹144.06
- Market cap
- ₹1,182 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 22.7×Sector 54.5×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Results Update
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
GPT Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare Dividend
GPT Healthcare's board declared an interim dividend of ₹1.00 per share for FY2026-27. Record date is November 12, 2026, with payment expected by December 4, 2026.
GPT Healthcare Q2 FY27 Results: Net Profit ₹15.4 Cr, Up 45.3% YoY
GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.
- Key figure
- Net profit ₹15.4 Cr · +45.3% YoY
GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.
GPT Healthcare Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).